Monoclonal clustering using double stranded DNA size exclusion with modeled vaccination
By inoculating double-stranded DNA onto a flow cell containing protein and lawn primers, using protein-ligand interactions to denature dsDNA, and amplifying the target nucleic acid sequence using lawn primers, the problem of noise and signal reduction in polyclonal clusters is solved. The generation efficiency and sequencing efficiency of monoclonal clusters are improved.
Patent Information
- Application Number
- CN202380031840.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-12-07
- Filing Date
- 2023-12-06
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
In the prior art, polyclonal clusters are affected by noise and signal reduction, resulting in a decrease in base recognition characteristics, and the production efficiency of monoclonal clusters is low, resulting in inefficient sequencing processes.
By inoculating double-stranded DNA (dsDNA) onto a flow cell containing protein and lawn primers, the protein-ligand interaction is used to denature dsDNA, and the target nucleic acid sequence is amplified using lawn primers to inhibit other inoculation events and improve the monoclonal cluster Generate efficiency.
It improves the generation efficiency of monoclonal clusters, reduces noise, enhances the base recognition characteristics, and improves the efficiency of the sequencing process.
Smart Images

Figure CN119095978A_ABST
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 430,936, filed on December 7, 2022, entitled “MONOCLONAL CLUSTERING USING DOUBLE-STRANDED DNA SIZE EXCLUSION WITH PATTERNED POTTING,” the entire contents of which are incorporated herein by reference. Technical Field
[0003] The present application relates to a method for monoclonal clustering. Background Art
[0004] Polyclonal clusters are affected by increased noise and decreased signal due to interference of the non-dominant template strand with the signal of the primary template population from the cluster. The resulting decreased signal and increased noise ultimately lead to reduced base recognition properties, even after purity filtering is applied. The ability to produce a higher proportion of monoclonal clusters is hindered by the Poisson nature of typical inoculation methods. In addition, the non-dominant strand is lost in the final readout, making the sequencing process inefficient when reading the available DNA on the flow cell. If inoculation is performed at a low density to increase the percentage of occupied monoclonal clusters, the total occupancy percentage is reduced, thereby reducing throughput. Summary of the invention
[0005] Embodiments provided herein relate to methods and compositions for amplifying target nucleic acid by inoculating double-stranded DNA (dsDNA) onto a circulation cell. In certain embodiments, the circulation cell includes protein, and the dsDNA is connected to a part that interacts with the protein. In certain embodiments, the circulation cell includes a plurality of lawn primers that are fixed on the circulation cell.
[0006] Some embodiments herein provide a method for amplifying a target nucleic acid, the method comprising inoculating double-stranded DNA (dsDNA) onto a flow cell, the flow cell comprising a first part comprising a protein and a second part comprising a plurality of lawn primers immobilized on the flow cell, wherein the dsDNA comprises a target nucleic acid sequence and a complementary nucleic acid sequence, and wherein the dsDNA is linked to a ligand, the ligand causing an interaction between the ligand and the protein; after the ligand interacts with the protein, denaturing the dsDNA to remove the complementary nucleic acid sequence; and amplifying the target nucleic acid sequence using the lawn primers.
[0007] In some embodiments, the plurality of lawn primers are capped at one end with a positive charge. In some embodiments, the positive charge causes the dsDNA to diffuse toward the first portion of the flow cell containing the protein.
[0008] In some embodiments, the method further comprises removing the positive charge from the lawn primer following the interaction between the ligand and the protein.
[0009] In some embodiments, the positive charge is removed by cleavage. In some embodiments, the positive charge is removed by melting.
[0010] In some embodiments, the protein is streptavidin and the ligand is biotin.
[0011] In some embodiments, the lawn primer comprises a P5 lawn primer. In some embodiments, the lawn primer comprises a P7 lawn primer. In some embodiments, the lawn primer comprises a P5 and a P7 lawn primer.
[0012] In some embodiments, the flow cell does not include any holes on its surface. In some embodiments, the flow cell includes holes on its surface. In some embodiments, the holes include small holes within large holes.
[0013] In some embodiments, seeding the flow cell with dsDNA inhibits other seeding events on the flow cell.
[0014] In some embodiments, the first portion of the flow cell is circular. In some embodiments, the first portion of the flow cell comprises a diameter between 80 nm and 100 nm. In some embodiments, the first portion of the flow cell is a circular pad.
[0015] Some embodiments herein provide a method of seeding double-stranded DNA (dsDNA) onto a flow cell, the method comprising seeding the dsDNA onto the flow cell, the flow cell comprising a first portion and a second portion, the first portion comprising a first biomolecule, the second portion comprising a plurality of lawn primers immobilized on the flow cell, wherein the dsDNA comprises a target nucleic acid sequence, and wherein the dsDNA is linked to a second biomolecule, resulting in an interaction between the second biomolecule and the first biomolecule.
[0016] In some embodiments, the first biomolecule and the second biomolecule interact with each other via a covalent interaction. In some embodiments, the first biomolecule and the second biomolecule interact with each other via a non-covalent interaction. In some embodiments, the non-covalent interaction comprises a protein-ligand interaction. In some embodiments, the protein-ligand interaction comprises a streptavidin-biotin interaction.
[0017] Some embodiments herein provide a flow cell comprising a surface comprising a first portion comprising a pad comprising a protein and a second portion comprising at least one of a P5 lawn primer and a P7 lawn primer.
[0018] In some embodiments, the second portion includes P5 and P7 lawn primers.
[0019] In some embodiments, at least one of the P5 lawn primer and the P7 lawn primer is capped with a positive charge.
[0020] In some embodiments, the surface comprises a patterned surface. In some embodiments, the patterned surface comprises at least one hole. In some embodiments, the at least one hole comprises at least one hole contained within at least one macropore.
[0021] In some embodiments, the patterned surface comprises a gel. In some embodiments, the gel comprises poly(N-(5-azidoacetamidopentyl)acrylamide-co-acrylamide) (PAZAM).
[0022] Some embodiments herein provide a flow cell comprising a surface coated with a primer, the primer being capped with a positive charge; and a pad comprising a protein, wherein the pad has a higher binding energy to dsDNA than the primer capped with a positive charge.
[0023] In some embodiments, the positive charge creates lower energy states at the surface of the flow cell.
[0024] In some embodiments, the protein comprises streptavidin.
[0025] In some embodiments, the positive charge is cleavable, allowing it to be removed from the primer.
[0026] It should be understood that any corresponding features / examples of each of the aspects of the present disclosure as described herein may be implemented together in any appropriate combination, and any features / examples from any one or more of these aspects may be implemented together with any of the features of the other (multiple) aspects as described herein in any appropriate combination to achieve the benefits as described herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 One embodiment of a pad is schematically shown, where the center is coated with streptavidin and the area around the center is coated with gel and grafted with P5 / P7 primers.
[0028] Figure 2 An example of a double-stranded DNA containing a biotin tag is schematically shown.
[0029] Figures 3A-3C An embodiment of a flow cell surface is schematically shown. Figure 3A An exemplary embodiment of a flow cell surface without a pore structure is schematically shown. Figure 3BAn exemplary embodiment of a flow cell surface comprising pores is schematically shown. Figure 3C An exemplary embodiment of a flow cell surface comprising small pores within large pores is schematically shown.
[0030] Figure 4 An embodiment of a surface primer on a flow cell is schematically shown, which includes a cleavable positive charge at the end of the lawn primer. Because dsDNA has a larger exclusion volume than ssDNA, polyclonality is reduced. The cleavable positive charge on the surface primer promotes the migration of dsDNA to the surface of the flow cell.
[0031] Figure 5A-5B Exemplary bar graphs demonstrating seeding of monoclonal fractions of dsDNA on nanowells are provided. Figure 5A The histograms in assume that a 15% overlap between template and well is required for binding to occur. Figure 5B The histograms in assume that a 30% overlap between template and well is required for binding to occur.
[0032] Figure 6 Example sampling using Monte Carlo simulation is shown.
[0033] Figures 7A-7D An exemplary manufacturing process is schematically illustrated. Fig. 7A An exemplary manufacturing flow lacking holes is schematically illustrated. Figure 7B An exemplary manufacturing flow in which a single hole is present is schematically shown. Figure 7C An exemplary manufacturing flow in which dual holes are present is schematically shown. Fig.7D An exemplary manufacturing flow including a polishing step prior to PZM deposition is schematically illustrated.
[0034] Figures 8A-8B Example groups attached to the ends of lawn primers that create a binding energy funnel are schematically shown. Fig. 8A Schematic illustration of a lawn primer capped with a positively charged group, wherein the positive charge is cleavable. Figure 8B Schematic representation of lawn primers capped with positive charges that can be removed by melting.
[0035] Figures 9A-9C An exemplary operation of a binding energy funnel is schematically illustrated. Fig.9A An example of a template chain preferentially diffusing toward a surface due to attraction to positive charges is schematically shown. Fig. 9B Schematic illustration of the capture of the template strand on the streptavidin pad. Fig. 9C Schematic showing how lawn primers containing positive charges generate relatively low energy states near the surface of the flow cell.
[0036] Fig.10 An example of a monoclonal clustering method using dsDNA is schematically illustrated.
[0037] Figures 11A-11C Schematic illustration of double-stranded DNA template seeding where the primer is capped with a positive charge. DETAILED DESCRIPTION
[0038] The examples provided herein are monoclonal clustering methods that are compatible with current library preparation protocols.
[0039] For example, as provided herein, a flow cell surface capable of clustering and inoculation is provided. Inoculation can be carried out on a pad comprising protein. Clustering can be carried out in the region of a flow cell coated with a gel and containing primers. Primers can be standard P5 and P7 primers. Template double-stranded DNA (dsDNA) can be labeled with a ligand, which can bind to proteins. dsDNA can be attached to the surface of the pad by the interaction of the ligand with the protein. Because DNA is dsDNA, rather than single-stranded DNA (ssDNA), it can potentially limit other inoculation events on the pad.
[0040] the term
[0041] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those of ordinary skill in the art. The use of the term "including" and other forms such as "include", "includes", and "included" is not restrictive. The use of the term "having" and other forms such as "have", "has", and "had" is not restrictive. As used in this specification, whether in a transitional phrase or in the body of the claim, the terms "including" and "comprising" will be interpreted as having an open meaning. That is, the above terms should be interpreted synonymously with the phrase "at least having" or "at least including". For example, when used in the context of a process, the term "comprising" means that the process includes at least the listed steps, but may also include additional steps. When used in the context of a compound, composition, or device, the term "comprising" means that the compound, composition, or device includes at least the listed features or components, but may also include additional features or components.
[0042] As used throughout this specification, the terms "substantially," "approximately," and "about" are used to describe and account for smaller fluctuations, such as due to variations in processing. For example, they may refer to less than or equal to ±10%, such as less than or equal to ±5%, such as less than or equal to ±2%, such as less than or equal to ±1%, such as less than or equal to ±0.5%, such as less than or equal to ±0.2%, such as less than or equal to ±0.1%, such as less than or equal to ±0.05%.
[0043] As used herein, "hybridize" is intended to mean that a first polynucleotide and a second polynucleotide non-covalently associate along the length of those polymers to form a double-stranded "duplex". For example, two DNA polynucleotide chains can associate by complementary base pairing. The strength of association between the first and second polynucleotides increases with the complementarity between the nucleotide sequences within those polynucleotides. The hybridization strength between polynucleotides can be characterized by the melting temperature (Tm), at which 50% of the duplexes have polynucleotide chains dissociated from each other. Polynucleotides that "partially" hybridize to each other mean that they have sequences that are complementary to each other, but such sequences only hybridize to each other along a portion of their length to form a partial duplex. Polynucleotides that "cannot" hybridize include those polynucleotides that are physically separated from each other, so that the number of their bases is insufficient to contact each other in a manner that hybridizes to each other.
[0044] As used herein, the term "nucleotide" is intended to mean a molecule comprising a sugar and at least one phosphate group, and in some examples, a nucleobase. Nucleotides lacking a nucleobase may be referred to as "abasic". Nucleotides include deoxyribonucleotides, modified deoxyribonucleotides, ribonucleotides, modified ribonucleotides, peptide nucleotides, modified peptide nucleotides, modified phosphate sugar backbone nucleotides, and mixtures thereof. Examples of nucleotides include adenosine monophosphate (AMP), adenosine diphosphate (ADP), adenosine triphosphate (ATP), thymidine monophosphate (TMP), thymidine diphosphate (TDP), thymidine triphosphate (TTP), cytidine monophosphate (CMP), cytidine diphosphate (CDP), cytidine triphosphate (CTP), guanosine monophosphate (GMP), guanosine diphosphate (GDP), guanosine triphosphate (GTP), uridine monophosphate (UMP), uridine diphosphate (UDP), uridine triphosphate (UTP), deoxyadenosine monophosphate (dAMP ), deoxyadenosine diphosphate (dADP), deoxyadenosine triphosphate (dATP), deoxythymidine monophosphate (dTMP), deoxythymidine diphosphate (dTDP), deoxythymidine triphosphate (dTTP), deoxycytidine diphosphate (dCDP), deoxycytidine triphosphate (dCTP), deoxyguanosine monophosphate (dGMP), deoxyguanosine diphosphate (dGDP), deoxyguanosine triphosphate (dGTP), deoxyuridine monophosphate (dUMP), deoxyuridine diphosphate (dUDP), and deoxyuridine triphosphate (dUTP).
[0045] As used herein, the term "nucleotide" is also intended to encompass any nucleotide analogs, which are nucleotides that contain a modified nucleobase, sugar, and / or phosphate moiety compared to a naturally occurring nucleotide. Exemplary modified nucleobases include inosine, xanthine, hypoxanthine, isocytosine, isoguanine, 2-aminopurine, 5-methylcytosine, 5-hydroxymethylcytosine, 2-aminoadenine, 6-methyladenine, 6-methylguanine, 2-propylguanine, 2-propyladenine, 2-thiouracil, 2-thiothymine, 2-thiocytosine, 15-halouracil, 15-halocytosine, 5-propynyluracil, 5-propynylcytosine, 6-azouracil, 6- Azocytosine, 6-azothymidine, 5-uracil, 4-thiouracil, 8-haloadenine or guanine, 8-aminoadenine or guanine, 8-thiol adenine or guanine, 8-sulfanyl adenine or guanine, 8-hydroxy adenine or guanine, 5-halogen substituted uracil or cytosine, 7-methylguanine, 7-methyladenine, 8-azaguanine, 8-azaadenine, 7-deazaguanine, 7-deazaadenine, 3-deazaguanine, 3-deazaadenine, etc. As known in the art, some nucleotide analogs cannot be incorporated into polynucleotides, for example nucleotide analogs such as 5'-phosphosulfate adenosine. Nucleotide can include any suitable number of phosphates, for example three, four, five, six or more than six phosphates.
[0046] As used herein, the term "polynucleotide" refers to a molecule comprising a sequence of nucleotides bound to each other. A polynucleotide is a non-limiting example of a polymer. Examples of polynucleotides include deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and their analogs. A polynucleotide can be a single-stranded sequence of nucleotides, such as RNA or single-stranded DNA; a double-stranded sequence of nucleotides, such as double-stranded DNA; or a mixture of single-stranded and double-stranded sequences of nucleotides can be included. Double-stranded DNA (dsDNA) includes genomic DNA, as well as PCR and amplification products. Single-stranded DNA (ssDNA) can be converted to dsDNA and vice versa. A polynucleotide can include non-naturally occurring DNA, such as enantiomeric DNA. The precise sequence of nucleotides in a polynucleotide may be known or unknown. The following are examples of polynucleotides: a gene or gene fragment (e.g., a probe, a primer, an expressed sequence tag (EST) or a serial analysis of gene expression (SAGE) tag), genomic DNA, a genomic DNA fragment, an exon, an intron, messenger RNA (mRNA), transfer RNA, ribosomal RNA, a ribozyme, cDNA, a recombinant polynucleotide, a synthetic polynucleotide, a branched polynucleotide, a plasmid, a vector, an isolated DNA of any sequence, an isolated RNA of any sequence, a nucleic acid probe, a primer, or an amplified copy of any of the foregoing.
[0047] As used herein, "polymerase" is intended to mean an enzyme with an active site for assembling polynucleotides by polymerizing nucleotides into polynucleotides. Polymerases can bind to the single-stranded target polynucleotides initiated, and nucleotides can be sequentially added to the growing primer to form a "complementary copy" polynucleotide having a sequence complementary to the sequence of the target polynucleotide. Then, another polymerase or the same polymerase can form a copy of the target nucleotide by forming a complementary copy of the complementary copy polynucleotide. Any of such copies may be referred to as "amplicon" herein. DNA polymerases can be bound to the target polynucleotides and then move down along the target polynucleotides, adding nucleotides sequentially to the free hydroxyl groups at the 3' end of the growing polynucleotide chain (growing amplicon). DNA polymerases can synthesize complementary DNA molecules from DNA templates and RNA polymerases can synthesize RNA molecules (transcription) from DNA templates. Polymerases can use short RNA or DNA chains (primers) to start chain growth. Some polymerases can cause them to add bases to the chain site upstream of the chain shift. Such polymerases can be referred to as strand-displaced, meaning that they have the activity of removing complementary strands from the template strands read by the polymerase. Exemplary polymerases with strand displacement activity include but are not limited to the large fragments of Bst (Bacillus stearothermophilus) polymerase, exo-Klenow polymerase or sequencing-grade T7 exo-polymerase. Some polymerases degrade the strands in front of them, thereby effectively displacing the strands in front of them (5' exonuclease activity) with the strands grown behind. Some polymerases have the activity (3' exonuclease activity) of degrading the strands behind them. Some useful polymerases have been modified to reduce or eliminate 3' and / or 5' exonuclease activity by mutation or otherwise.
[0048] As used herein, the term "primer" is defined as a polynucleotide to which nucleotides can be added by free 3'OH groups. Primers can include 3' blocking groups that can prevent polymerization until the blocking groups are removed. Primers can include modifications at the 5' end to allow coupling reactions or to couple the primer to another part. Primers can include one or more parts that can be cleaved under suitable conditions (such as UV light, chemistry, enzymes, etc.). Primer length can be the length of any suitable number of bases, and can include any suitable combination of natural and non-natural nucleotides. Target polynucleotides can include "adapters", which can hybridize with primers (having sequences complementary to primers), and can be amplified to generate complementary replication polynucleotides by adding nucleotides to the free 3'OH groups of primers. "Capture primers" are intended to represent primers that are coupled to substrates and can hybridize with the second adapter of target polynucleotides, while "orthogonal capture primers" are intended to represent primers that are coupled to substrates and can hybridize with the first adapter of the target polynucleotides. The first adapter may have a sequence that is complementary to the sequence of the orthogonal capture primer, and the second adapter may have a sequence that is complementary to the sequence of the capture primer. The capture primer and the orthogonal capture primer may have sequences that are different and independent from each other. In addition, the capture primer and the orthogonal capture primer may differ from each other in at least one other characteristic. For example, the capture primer and the orthogonal capture primer may have different lengths from each other; the capture primer or the orthogonal capture primer may include a non-nucleic acid portion (such as a blocking group or an excision portion) that is lacking in the other of the capture primer or the orthogonal capture primer; or any suitable combination of such characteristics.
[0049] As used herein, the term "substrate" refers to the material used as a support for the composition described herein. Exemplary substrate materials may include glass, silicon dioxide, plastic, quartz, metal, metal oxide, organosilicate (e.g., polyhedral organosiliconesquioxane (POSS)), polyacrylate, tantalum oxide, complementary metal oxide semiconductor (CMOS), or a combination thereof. The example of POSS may be described in Kehagias et al., Microelectronic Engineering (Microelectronic Engineering) 86 (2009), POSS in pages 776-778, which is incorporated by reference in its entirety. In some examples, the substrate used in the present application includes a silicon dioxide-based substrate, such as glass, fused silica, or other silicon dioxide-containing materials. In some examples, the substrate may include silicon, silicon nitride, or hydrogenated silicone. In some examples, the substrate used in the present application includes a plastic material or component, such as polyethylene, polystyrene, poly (vinyl chloride), polypropylene, nylon, polyester, polycarbonate, and poly (methyl methacrylate). Exemplary plastic materials include poly(methyl methacrylate), polystyrene, and cycloolefin polymer substrates. In some examples, the substrate is or includes a silicon dioxide-based material or a plastic material or a combination thereof. In a specific example, the substrate has at least one surface including glass or a silicon-based polymer. In some examples, the substrate may include a metal. In some such examples, the metal is gold. In some examples, the substrate has at least one surface including a metal oxide. In one example, the surface includes tantalum oxide or tin oxide. Acrylamide, enone, or acrylate may also be used as a substrate material or component. Other substrate materials may include but are not limited to gallium arsenide, indium phosphide, aluminum, ceramics, polyimide, quartz, resins, polymers, and copolymers. In some examples, the substrate and / or the substrate surface may be or include quartz. In some other examples, the substrate and / or the substrate surface may be or include a semiconductor such as GaAs or ITO. The foregoing list is intended to illustrate but is not limited to the present application. The substrate may include a single material or a plurality of different materials. The substrate may be a composite or a laminate. In some examples, the substrate includes an organic silicate material. The substrate can be flat, round, spherical, rod-shaped, or any other suitable shape. The substrate can be rigid or flexible. In some examples, the substrate is a bead or a flow cell.
[0050] In some examples, the substrate comprises a patterned surface. "Patterned surface" refers to the arrangement of different regions in or on the exposed layer of the substrate. For example, one or more of the regions may be features in which one or more capture primers are present. Features may be separated by gap regions in which there are no capture primers. In some examples, the pattern may be features in the form of xy in rows and columns. In some examples, the pattern may be features and / or gap regions that are repeatedly arranged. In some examples, the pattern may be features and / or gap regions that are randomly arranged. In some examples, the substrate comprises an array of holes (depressions) in the surface. The hole may be provided by a substantially vertical sidewall. The hole may be manufactured using a variety of techniques as generally known in the art, including but not limited to photolithography, imprinting techniques, molding techniques, and micro-etching techniques. Those skilled in the art will appreciate that the techniques used will depend on the composition and shape of the array substrate.
[0051] The features in the patterned surface of the substrate may include wells (e.g., microwells or nanowells) in an array of wells on glass, silicon, plastic, or other suitable material with a patterned covalently attached gel, such as poly(N-(5-azidoacetamidopentyl)acrylamide-co-acrylamide) (PAZAM or PZM). The process produces a gel pad for sequencing that can be stable over sequencing runs with a large number of cycles. The covalent attachment of the polymer to the wells can help maintain the gel as a structured feature throughout the life of the structured substrate during a variety of uses. However, in many examples, the gel need not be covalently attached to the wells. For example, under some conditions, a silane-free acrylamide (SFA) that is not covalently attached to any portion of the structured substrate can be used as the gel material.
[0052] In a specific example, a structured substrate can be made by patterning a suitable material with pores (e.g., micropores or nanopores), coating the patterned material with a gel material (e.g., PAZAM, SFA, or chemically modified variants thereof, such as an azidated form of SFA (azido-SFA)), and polishing the surface of the gel-coated material, for example by chemical or mechanical polishing, thereby retaining the gel in the pores, but removing or inactivating substantially all of the gel from the interstitial regions on the surface of the structured substrate between the pores. Primers can be attached to the gel material. A solution containing a plurality of target polynucleotides (e.g., a fragmented human genome or a portion thereof) can then be contacted with the polished substrate so that individual target polynucleotides will seed individual pores by interacting with primers attached to the gel material; however, due to the absence or inactivity of the gel material, the target polynucleotides will not occupy the interstitial regions. Because the absence or inactivity of the gel in the interstitial regions can prevent the outward migration of growth clusters, the amplification of the target polynucleotides can be confined to the pores. The process can be conveniently manufactured, scalable, and utilizes conventional micro- or nano-manufacturing methods.
[0053] The patterned substrate may include, for example, holes etched into a slide or chip. The pattern and geometry of the hole etching may be in a variety of different shapes and sizes, and such features may be physically or functionally separated from each other. Particularly useful substrates with such structural features include patterned substrates that can select the size of solid particles such as microspheres. An exemplary patterned substrate with these features is an etched substrate used in conjunction with BEAD ARRAY technology (Illumina, San Diego, CA).
[0054] In some examples, the substrate described herein forms at least a portion of a flow cell, is located in a flow cell, or is coupled to a flow cell. The flow cell may include a flow chamber divided into a plurality of lanes or a plurality of partitions. Exemplary flow cells that can be used in the methods and compositions described herein and substrates for making flow cells include but are not limited to those available from Illumina, Inc. (San Diego, California).
[0055] As used herein, when used with reference to polynucleotides, the term "fixed" is intended to mean directly or indirectly attached to a substrate by covalent or non-covalent bonds. In some examples, covalent attachment or any other suitable attachment may be used, wherein the polynucleotide remains fixed or attached to a substrate under conditions intended to use the substrate (e.g., in polynucleotide amplification or sequencing). The polynucleotide to be used as a capture primer or as a target polynucleotide may be fixed so that the 3'-end can be used for enzymatic extension, and at least a portion of the sequence can hybridize with a complementary sequence. Fixation may occur by hybridization with an oligonucleotide attached to a surface, in which case the fixed oligonucleotide or polynucleotide may be in a 3'-5' orientation. Alternatively, fixation may occur by means other than base pairing hybridization (such as covalent attachment).
[0056] As used herein, the term "array" refers to a group of substrate regions that can be distinguished from each other according to relative positions. Different molecules (such as polynucleotides) located at different regions of the array can be distinguished from each other according to the positions of these regions in the array. A single region of an array may include one or more specific types of molecules. For example, a substrate region may include a single target polynucleotide with a specific sequence, or a substrate region may include several polynucleotides with the same sequence (or its complementary sequence). The regions of the array may include different features on the same substrate, respectively. Exemplary features include, but are not limited to, holes in substrates, beads (or other particles) in or on substrates, protrusions of substrates, ridges on substrates, or channels in substrates. The regions of the array may include different regions on substrates that are different from each other. Different molecules attached to a separate substrate may be identified according to the position of the substrate on a surface associated with the substrate, or according to the position of the substrate in a liquid or gel. Exemplary arrays in which separate substrates are located on the surface include, but are not limited to, those arrays with beads in holes.
[0057] As used herein, the term "plurality" is intended to mean a population of two or more different members. The plurality may range in size from small, medium, large to extremely large. The size of a small plurality may range, for example, from a few members to tens of members. A medium-sized plurality may range, for example, from tens of members to about 100 members or hundreds of members. A large plurality may range, for example, from about hundreds of members to about 1000 members, to thousands of members, and up to tens of thousands of members. An extremely large plurality may range, for example, from tens of thousands of members to about hundreds of thousands, one million, several million, tens of millions, and up to or exceeding hundreds of millions of members. Thus, the size of a plurality measured in terms of the number of members may range from two to well over 100 million members, as well as all sizes between and over the above exemplary ranges. A plurality of exemplary polynucleotides includes, for example, about 1×10 5 or more, 5×10 5or more or 1×10 6 or more different polynucleotides. Thus, the definition of the term is intended to include all integer values greater than two. The upper limit of the plurality of numbers can be set, for example, by the theoretical diversity of the polynucleotide sequences in the sample.
[0058] As used herein, the term "double-stranded" when used with reference to a polynucleotide is intended to mean that all or substantially all of the nucleotides in a polynucleotide are hydrogen bonded to corresponding nucleotides in a complementary polynucleotide. A "partially" double-stranded polynucleotide may have at least about 10%, at least about 25%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, or at least about 95% of its nucleotides hydrogen bonded to nucleotides in a complementary polynucleotide, but less than all of its nucleotides hydrogen bonded to nucleotides in a complementary polynucleotide.
[0059] As used herein, the term "single-stranded" when used in reference to a polynucleotide means that substantially none of the nucleotides in the polynucleotide are hydrogen bonded to corresponding nucleotides in a complementary polynucleotide. A polynucleotide that is "incapable" of hybridizing to another polynucleotide may be single-stranded.
[0060] As used herein, the term "target polynucleotide" is intended to mean a polynucleotide that is the object of analysis or action. Analysis or action includes subjecting the polynucleotide to amplification, sequencing, and / or other procedures. The target polynucleotide may include a nucleotide sequence other than the target sequence to be analyzed. For example, the target polynucleotide may include one or more adapters, including adapters that act as primer binding sites, and the adapters flank the target polynucleotide sequence to be analyzed. The target polynucleotide hybridized with the capture primer may include nucleotides that extend beyond the 5' end or 3' end of the capture oligonucleotide in a manner that not all target polynucleotides are easy to extend. In a specific example, the target polynucleotide may have sequences that are different from each other, but may have a first adapter and a second adapter that are identical to each other. Two adapters that may be located on the flanks of a specific target polynucleotide sequence may have sequences that are identical to each other, or sequences that are complementary to each other, or the two adapters may have different sequences. Therefore, the species in a plurality of target polynucleotides may include a region of known sequence that is located on the flanks of an unknown sequence region that will be evaluated by, for example, sequencing (e.g., SBS). In some examples, the target polynucleotide carries an adaptor at a single end, and such adaptor may be located at the 3' end or the 5' end of the target polynucleotide. The target polynucleotide may be used without any adaptor, in which case the primer binding sequence may be derived directly from a sequence found in the target polynucleotide.
[0061] The terms "polynucleotide" and "oligonucleotide" are used interchangeably herein. Unless specifically indicated otherwise, the different terms are not intended to represent any specific differences in size, sequence, or other properties. For clarity of description, when describing a specific method or composition comprising several polynucleotide species, the terms may be used to distinguish one polynucleotide species from another species.
[0062] As used herein, the term "amplicon" when used with respect to a polynucleotide is intended to mean a product of replicating a polynucleotide, wherein the product has a nucleotide sequence that is substantially identical to at least a portion of the nucleotide sequence of the polynucleotide or substantially complementary to at least a portion of the nucleotide sequence of the polynucleotide. "Amplification" and "amplifying" refer to the process of making an amplicon of a polynucleotide. The first amplicon of a target polynucleotide can be a complementary duplicate. Additional amplicons are duplicates generated from a target polynucleotide or from a first amplicon after the first amplicon is generated. Subsequent amplicons may have a sequence that is substantially complementary to the target polynucleotide or substantially identical to the target polynucleotide. It should be understood that when an amplicon of a polynucleotide is generated, a small amount of mutations of the polynucleotide may occur (e.g., due to amplification artifacts).
[0063] Substrate regions that substantially only include amplicons of a given polynucleotide may be referred to as "monoclonal", while substrate regions that include amplicons of polynucleotides having sequences that differ from each other may be referred to as "polyclonal". Substrate regions that include amplicons of a sufficient number of given polynucleotides to be used for sequencing may be referred to as "functionally monoclonal". Illustratively, a substrate region in which there are about 60% or more amplicons of a given polynucleotide may be considered "functionally monoclonal". Additionally or alternatively, a substrate region from about 60% or more of the signal may be considered "functionally monoclonal", which signal comes from the amplicons of a given polynucleotide. The polyclonal region of a substrate may include different subregions that are monoclonal, respectively. Each such monoclonal region, whether within a larger polyclonal region or alone, may be equivalent to a "cluster" generated from a "seed". A "seed" may refer to a single target polynucleotide, while a "cluster" may refer to a collection of amplicons of the target polynucleotide.
[0064] As used herein, the term "biomolecule" is any compound found in living organisms and capable of carrying out a biological process. A "biomolecule" can be a macromolecule or a small molecule. A "biomolecule" can be a molecule that is capable of binding to another compound (e.g., another "biomolecule"). These binding interactions can include binding between two (2) macromolecules, binding between two (2) small molecules, or binding between a macromolecule and a small molecule. Examples of binding events include binding between two (2) proteins or binding between a protein and a ligand.
[0065] Some embodiments described herein include flow cells containing both "small holes" and "large holes" (e.g., flow cells containing double holes). The term "small hole" refers to a hole in which double-stranded DNA seeding occurs. In some embodiments, the surface length of the "small hole" is equal to or less than about twice the length of the radius of gyration of the double-stranded DNA seeded on the surface. In some embodiments, the "small hole" may contain a pad on which the seeding is performed, and in some embodiments, the pad has about the same length as the hole. The term "large hole" refers to a hole that is larger than the "small hole" in the flow cell. The "large hole" is a hole in which clustering occurs.
[0066] Monoclonal clustering method using flow cells and double-stranded DNA
[0067] Some embodiments herein provide a method for amplifying a target nucleic acid sequence, the method comprising inoculating double-stranded DNA (dsDNA) onto a flow cell, the flow cell comprising a first portion comprising a protein and a second portion comprising a plurality of lawn primers immobilized on the flow cell, wherein the dsDNA comprises a target nucleic acid sequence and a complementary nucleic acid sequence, and wherein the dsDNA is linked to a ligand that causes an interaction with the protein; after the ligand interacts with the protein, denaturing the dsDNA to remove the complementary nucleic acid sequence; and amplifying the target nucleic acid sequence using the lawn primers.
[0068] In some embodiments, inoculating dsDNA onto the flow cell prevents other inoculation events on the flow cell. In some embodiments, inoculating dsDNA onto the flow cell inhibits other inoculation events on the flow cell. In some embodiments, it is the size of the dsDNA that prevents other inoculation events.
[0069] In some embodiments, the flow cell comprises a pad, and the inoculation of the dsDNA occurs on the pad. In some embodiments, the protein on the flow cell is on the pad. In some embodiments, the pad is coated with a gel. In some embodiments, the gel comprises PAZAM. In some embodiments, the gel comprises any gel described herein.
[0070] In some embodiments, the plurality of lawn primers are capped with a positive charge at one end. In some embodiments, the positive charge is reversibly bound to the lawn primer. In some embodiments, the method further comprises removing the positive charge from the lawn primer after the interaction between the ligand and the protein. In some embodiments, the positive charge is removed by cleavage. In some embodiments, the positive charge is removed by melting.
[0071] In some embodiments, the positive charge causes the dsDNA to diffuse into the first portion of the flow cell containing the protein.
[0072] In some embodiments, the method further comprises migrating the dsDNA to the surface of the flow cell. In some embodiments, removing positive charges facilitates the migrating step.
[0073] In some embodiments, the protein is streptavidin. In some embodiments, the ligand is biotin. In some embodiments, the protein is glutathione-S-transferase. In some embodiments, the ligand is glutathione. In some embodiments, the protein is maltose binding protein. In some embodiments, the ligand is maltose. In some embodiments, the protein and ligand are any protein and ligand that can interact with each other.
[0074] In some embodiments, the lawn primer comprises a P5 lawn primer. In some embodiments, the lawn primer comprises a P7 lawn primer. In some embodiments, the lawn primer comprises a P5 and a P7 lawn primer.
[0075] In some embodiments, the flow cell does not include any holes on its surface. In some embodiments, the flow cell includes at least one hole on its surface. In some embodiments, the flow cell includes at least one small hole within at least one large hole on the flow cell surface.
[0076] In some embodiments, the first portion of the flow cell is circular. In some embodiments, the first portion of the flow cell includes a circular pad. In some embodiments, the circular pad includes a diameter between about 80nm and about 100nm. In some embodiments, the diameter is less than about 80nm. In some embodiments, the diameter is greater than about 100nm.
[0077] Figure 1 An embodiment of a flow cell surface is shown, the flow cell surface comprising a pad coated with protein 10 and an area around the pad comprising a lawn primer. In some embodiments, the protein is a receptor. In some embodiments, the protein is streptavidin. In some embodiments, the protein is any protein capable of binding a ligand. In some embodiments, the lawn primer comprises a P5 primer, a P7 primer, or a combination of a P5 primer and a P7 primer. Figure 2 A double stranded DNA 20 is illustrated which is linked to a ligand 25. In some embodiments, the ligand is any ligand capable of binding to a receptor. In some embodiments, the ligand comprises biotin.
[0078] Some embodiments herein provide a method of seeding dsDNA onto a flow cell, the method comprising seeding double-stranded DNA (dsDNA) onto a flow cell, the flow cell comprising a first portion and a second portion, the first portion comprising a biomolecule, the second portion comprising a plurality of lawn primers immobilized on the flow cell, wherein the dsDNA comprises a target nucleic acid sequence, and wherein the dsDNA is linked to a second biomolecule, which results in an interaction between the second biomolecule and the first biomolecule.
[0079] In some embodiments, the first biomolecule and the second biomolecule interact with each other via a covalent interaction. In some embodiments, the first biomolecule and the second biomolecule interact with each other via a non-covalent interaction. In some embodiments, the non-covalent interaction comprises a protein-ligand interaction. In some embodiments, the protein-ligand interaction comprises a streptavidin-biotin interaction.
[0080] In some embodiments, detecting the interaction between the first biomolecule and the second biomolecule comprises a sequencing reaction. In some embodiments, the sequencing reaction comprises an amplification reaction. In some embodiments, the amplification reaction comprises bridge amplification or ex-amp.
[0081] Flow cell
[0082] Some embodiments herein provide a flow cell comprising a surface comprising a first portion comprising a pad coated with a protein and a second portion coated with at least one of a P5 lawn primer and a P7 lawn primer.
[0083] In some embodiments, the second portion is coated with both P5 and P7 lawn primers. In some embodiments, at least one of the P5 lawn primer and the P7 lawn primer is covered with a positive charge.
[0084] In some embodiments, the positive charge has a specific size such that it neutralizes the repulsive force of the negative charge on the lawn primer. In some embodiments, the positive charge has a specific length such that it neutralizes the repulsive force of the negative charge on the lawn primer.
[0085] In some embodiments, the positive charge comprises a molecule containing multiple positive charges. In some embodiments, the molecule containing multiple positive charges is polylysine, polyspermine, polyethyleneimine, and similar molecules.
[0086] In some embodiments, the positive charge can be removed from the primer by cleaving the positive charge from the primer. In some embodiments, the positive charge can be removed from the primer by melting.
[0087] In some embodiments, the surface is made of glass. In some embodiments, the surface is made of silicon. In some embodiments, the surface is made of plastic. In some embodiments, the surface comprises a patterned surface. In some embodiments, the patterned surface comprises at least one hole. In some embodiments, the at least one hole comprises at least one small hole contained within at least one large hole.
[0088] In some embodiments, the patterned surface comprises a gel. In some embodiments, the gel comprises poly(N-(5-azidoacetamidopentyl)acrylamide-co-acrylamide) (PAZAM). In some embodiments, the gel comprises SFA. In some embodiments, the gel comprises azido-SFA.
[0089] In some embodiments, the P5 and P7 primers coated on the second portion are attached to the gel.
[0090] In some embodiments, the protein coated on the first portion is streptavidin. In some embodiments, the protein coated on the first portion is any protein capable of binding to a ligand.
[0091] Some embodiments herein provide a flow cell comprising (i) a pad coated with a protein and (ii) a pad coated with a primer, wherein the protein and the primer are separated. In some embodiments, the primer is a P5 primer, a P7 primer, or a combination of a P5 and a P7 primer.
[0092] Figure 3A An exemplary embodiment of a flow cell comprising no pores is shown. The flow cell surface 40 comprises small conjugate pads 35. Figure 3B An exemplary embodiment of a flow cell comprising one (1) well is shown. A small conjugate pad 45 is located on the flow cell surface 55 within the well structure 50. Figure 3C shows an exemplary embodiment of a flow cell comprising a small hole 65 within a large hole 70. A small conjugate pad 75 is located on the flow cell surface 60 within the small hole. Figures 3A-3C In any of the flow cells exemplified in , the small binding pad can be coated with a protein. The protein can be a receptor, or any other protein capable of binding a ligand. In some embodiments, the protein is streptavidin. Figures 3A-3C In any of the flow cells exemplified in , the surface of the flow cell is coated with primers, such as P5 primers, P7 primers, or a combination of P5 and P7 primers.
[0093] Some embodiments herein provide a flow cell comprising a surface coated with a primer, the primer being capped with a positive charge; and a pad coated with a protein, wherein the pad has a higher binding energy to dsDNA than the primer capped with a positive charge.
[0094] In some embodiments, the pad is circular. In some embodiments, the diameter of the circular pad is at least 50 nm. In some embodiments, the diameter of the circular pad is at least about 60 nm. In some embodiments, the diameter of the circular pad is at least about 70 nm. In some embodiments, the diameter of the circular pad is at least about 80 nm. In some embodiments, the diameter of the circular pad is at least about 90 nm. In some embodiments, the diameter of the circular pad is at least about 100 nm. In some embodiments, the diameter of the circular pad is at least about 110 nm. In some embodiments, the diameter of the circular pad is at least about 120 nm. In some embodiments, the diameter of the circular pad is at least about 130 nm. In some embodiments, the diameter of the circular pad is at least about 130 nm. In some embodiments, the diameter of the circular pad is at least about 140 nm. In some embodiments, the diameter of the circular pad is at least about 150 nm. In some embodiments, the diameter of the circular pad is less than about 50 nm. In some embodiments, the diameter of the circular pad is greater than about 150 nm.
[0095] In some embodiments, the protein is streptavidin. In some embodiments, the positive charge creates a lower energy state at the surface of the pad labeled with streptavidin. Fig. 9C An example is shown where the positive charge results in a lower energy state at the surface of a streptavidin coated pad (labeled SA pad). In some embodiments, the positive charge is cleavable so that it can be removed from the primer.
[0096] like Fig.9A As shown in , the positive charge on the primer can generate a binding energy funnel, in which the dsDNA including the template strand 200 bound to the ligand 220 (such as biotin) preferentially diffuses to the surface of the flow cell via attraction to the positive charge 205 on the lawn primer 210. Fig. 9B This illustrates that when the template strand diffuses near the surface, the dsDNA is attached to the template / dsDNA through the interaction of the streptavidin pad 215 and the ligand 220 .
[0097] Manufacturing Process
[0098] Various fabrication process methods can be used to pattern the flow cell.
[0099] Fig. 7A An exemplary manufacturing process lacking holes is schematically shown. The patterned surface 95 can be on a material 98 such as glass, silicon, plastic, or any other suitable material. The patterned surface is coated with streptavidin (SA) 100 or other suitable protein. The surface can be coated with streptavidin, other suitable proteins, using liquid phase "immersion", spin coating, or droplet dispensing.
[0100] The flow cell comprises a patterned stripping mask. The mask can be made of metal, such as aluminum, steel, iron, copper, brass, zinc, bronze or magnesium. The metal can be patterned by photolithography and etching. The thickness of the mask can be between about 50nm and about 150nm. In some cases, the thickness of the mask is less than 50nm. In some cases, the thickness of the mask is greater than about 150nm.
[0101] After the stripping step, a protein-coated (e.g., streptavidin-coated) patterned surface is left 100. The stripping step is performed with a chemical that removes metals (e.g., aluminum) but not proteins (e.g., streptavidin). The surface is then coated with PAZAM 105 or other suitable gel material.
[0102] Figure 7B An exemplary fabrication flow is schematically shown in which a single well 111 is present. The patterned surface 110 may be on a material 113 such as glass, silicon, plastic, or any other suitable material. The patterned surface is coated with a protein such as streptavidin 115, which results in the wells 111 being coated with the protein (e.g., streptavidin) 115. The surface may be coated with the protein (e.g., streptavidin) using liquid phase "immersion," spin coating, or droplet dispensing.
[0103] The flow cell comprises a patterned stripping mask. The mask can be made of metal, such as aluminum, steel, iron, copper, brass, zinc, bronze or magnesium. The metal can be patterned by photolithography and etching. The thickness of the mask can be between about 50nm and about 150nm. In some cases, the thickness of the mask is less than about 50nm. In some cases, the thickness of the mask is greater than about 150nm.
[0104] After the stripping step, only the wells 111 remain coated with the protein (e.g., streptavidin) 115. The stripping step is performed with a chemical that removes metal (e.g., aluminum) from the wells but not the protein (e.g., streptavidin). The patterned surface 110 and wells 111 are then coated with PAZAM 118 or other suitable gel material.
[0105] Figure 7C An example fabrication flow is schematically shown, where there are dual wells, an upper well (large well) 125 and a lower well (small well) 128. The patterned surface 120 may be on a material 123 such as glass, silicon, plastic, or any other suitable material. The patterned surface is coated with a protein (e.g., streptavidin), which results in the upper well 125 being coated with the protein (e.g., streptavidin) 126 and the lower well 128 being coated with the protein (e.g., streptavidin) 126. The surface may be coated with the protein (e.g., streptavidin) using liquid phase "immersion", spin coating, or droplet dispensing.
[0106] The flow cell comprises a patterned stripping mask. The mask can be made of metal, such as aluminum, steel, iron, copper, brass, zinc, bronze or magnesium. The metal can be patterned by photolithography and etching. The thickness of the mask can be between 50nm and 150nm. In some cases, the thickness of the mask is less than about 50nm. In some cases, the thickness of the mask is greater than about 150nm.
[0107] After the stripping step, only the lower wells 128 remain coated with the protein (e.g., streptavidin) 126. The stripping step is performed with a chemical that removes metals (e.g., aluminum) but not proteins (e.g., streptavidin). The surface is then coated with PAZAM 130 or other suitable gel material.
[0108] Fig.7D An exemplary fabrication flow including a polishing step prior to PAZAM deposition (or deposition with another suitable gel material) is schematically shown. The patterned surface 131 is coated with a protein (e.g., streptavidin), which results in pores 132 being coated with a protein (e.g., streptavidin) 150. The surface can be coated with a protein (e.g., streptavidin) using liquid phase "immersion", spin coating, or droplet dispensing.
[0109] After coating with streptavidin or other suitable protein, a masking material 140 is deposited. An example of a masking material is a carbon hard mask. The substrate is then polished to remove the streptavidin coated outside the holes and to remove the masking layer deposited outside the holes.
[0110] A layer of PAZAM (or other suitable gel material) is deposited, and the mask layer is stripped off. The chemicals used for stripping will only remove the mask material, leaving PAZAM 145 or other suitable gel material and protein (eg, streptavidin) 150 on the wells.
[0111] Bridge Amplification
[0112] Bridge amplification can occur on a circulation cell. Double-stranded template DNA is hybridized with lawn primers in the circulation cell, and polymerase is used to extend the primers to form double-stranded DNA. The double-stranded DNA is denatured, and the original template strand of the DNA molecule is washed away. This causes single-stranded DNA molecules to bind to the lawn primers in the circulation cell. The single-stranded DNA molecules flip and form a "bridge" by hybridizing with adjacent lawn primers that are complementary to the sequence of the single-stranded DNA molecules. The polymerase extends the hybridized primers, resulting in bridge amplification of the DNA molecules and the generation of double-stranded DNA molecules. The double-stranded DNA molecules are then denatured to produce two copies of the single-stranded template, one of which is fixed on a support and the other can be washed away. The copy fixed as a carrier can be used for further bridge amplification operations to produce clusters that can be sequenced subsequently.
[0113] Nucleic acid and template libraries
[0114] As will be appreciated by the technician, double-stranded nucleic acid will generally be formed by two complementary polynucleotide chains, which are composed of deoxyribonucleotides connected by phosphodiester bonds, but may additionally include one or more ribonucleotides and / or non-nucleotide chemical moieties and / or non-naturally occurring nucleotides and / or non-naturally occurring backbone bonds. Specifically, double-stranded nucleic acid may include non-nucleotide chemical moieties, such as joints or spacers at the 5' ends of one or two chains. As non-limiting examples, double-stranded nucleic acid may include methylated nucleotides, uracil bases, thiophosphate groups, and may also include peptide conjugates, etc. Such non-DNA or non-natural modifications may be included to impart some desired characteristics to nucleic acid, such as for realizing covalent attachment, non-covalent attachment or metal coordination attachment to a solid support, or serve as a spacer to position the cleavage site to the optimal distance from a solid support.
[0115] An example of a typical double-stranded nucleic acid template (which may be provided in a library of such templates) is shown in Fig.11A In one embodiment, the first strand of the template includes, in the 5' to 3' direction, a first lawn primer binding sequence (e.g., P5), an index sequence (e.g., i5), a first sequencing primer binding site (e.g., SBS3), an insertion sequence corresponding to the template DNA to be sequenced, a second sequencing primer binding site (e.g., SBS12'), a second index sequence (e.g., i7'), and a second lawn primer binding sequence (e.g., a complementary sequence to P7). The second strand of the template includes, in the 3' to 5' direction, a first lawn primer binding site (e.g., a complementary sequence to P5), an index sequence (e.g., i5', which is complementary to i5), a first sequencing primer binding site (e.g., SBS3', which is complementary to SBS3), an insertion sequence corresponding to the complementary sequence of the template DNA to be sequenced, a second sequencing primer binding site (e.g., SBS12, which is complementary to SBS12), a second index sequence (e.g., i7, which is complementary to i7), and a second lawn primer binding sequence (e.g., P7).
[0116] like Fig. 11B As shown in , the double stranded DNA may include a biotin tag 300, which can be used to bind to a streptavidin-coated pad on the surface of the flow cell. During library preparation, the double stranded DNA may be labeled with a biotin tag. Fig. 11C As shown, the P5 and P7 lawn primers may contain a positively charged molecule 305 at one end thereof.
[0117] In some embodiments, the primer binding sequence of the adaptor is complementary to a short primer sequence (or lawn primer) present on the surface of the flow cell. Binding of appropriate portions of the adaptor to their complements (P5 and P7) on the surface of, for example, a flow cell allows nucleic acid amplification.
[0118] The length of the primer binding sequence in the adapter that allows hybridization with the amplification (lawn) primer is generally about 20-40 nucleotides, although in an embodiment, the disclosure is not limited to sequences of this length. The exact identity in the amplification primer, and therefore the homologous sequence in the adapter is generally unimportant for the disclosure, as long as the primer binding sequence can interact with the amplification primer to guide amplification. The sequence of the amplification primer can have specificity to the specific target nucleic acid of the desired amplification, but in other embodiments, these sequences can be "universal" primer sequences, which can amplify any target nucleic acid with known or unknown sequence, and these target nucleic acids have been modified to be able to amplify with universal primers. The design criteria of PCR primers are generally well known to those of ordinary skill in the art. In the present disclosure, "primer binding sequence" may also be referred to as "clustering sequence", "clustering primer" or "cluster primer", and such terms are interchangeably used.
[0119] Index sequences (also referred to as barcodes or tag sequences) are unique short DNA sequences that are added to each DNA fragment during library preparation. Unique sequences allow many libraries to be merged together and sequenced simultaneously. Before final data analysis, sequencing reads from the merged libraries are identified and classified by calculation based on their barcodes. Library multiplexing is also a useful technique when working with small genomes or targeting genomic regions of interest. Multiplexing with barcodes can exponentially increase the number of samples analyzed in a single run without significantly increasing running costs or running time. Examples of tag sequences exist in WO05068656, the entire contents of which are incorporated herein by reference. The tag can be read at the end of the first read, or it can also be read at the end of the second read. The present disclosure is not limited to the number of reads per cluster, such as two reads per cluster: three or more reads per cluster can be obtained simply by dehybridizing the first extended sequencing primer and hybridizing the second primer before or after the cluster re-growth / chain resynthesis step. Methods for preparing suitable samples for indexing are described, for example, in US Pat. No. 8,822,150, the entire contents of which are incorporated herein by reference. Single or dual indexes may also be used. Using a single index, up to 48 unique 6-base indexes may be used to generate a library of up to 48 unique markers. Using a dual index, up to 24 unique 8-base index 1 sequences and up to 16 unique 8-base index 2 sequences may be used in combination to generate a library of up to 384 unique markers. Index pairs may also be used so that each i5 index and each i7 index are used only once. Using these unique dual indexes, it is possible to identify and filter skipped reads of the index, thereby providing even higher confidence in multiplexed samples.
[0120] The sequencing binding site is a sequencing and / or index primer binding site, and indicates the starting point of sequencing reading. During the sequencing process, the sequencing primer anneals (i.e., hybridizes) with a portion of the sequencing binding site on the template strand. DNA polymerase binds to the site, and the complementary nucleotides are incorporated into the growing opposite strand one by one. In one embodiment, the sequencing process includes a first sequencing read and a second sequencing read. The first sequencing read may include the combination of the first sequencing primer (reading 1 sequencing primer) with the first sequencing binding site (e.g., SBS3'), followed by the synthesis and sequencing of the complementary strand. This results in the sequencing of the inserted sequence. In the second step, the index sequencing primer (e.g., i7 sequencing primer) is bound to the second sequencing binding site (e.g., SBS12), thereby resulting in the synthesis and sequencing of the index sequence (e.g., sequencing of the i7 primer). The second sequencing read may include the combination of the index sequencing primer (e.g., i5 sequencing primer) with the complementary sequence (e.g., SBS3) of the first sequencing binding site on the template, and the synthesis and sequencing of the index sequence (e.g., i5). In the second step, a second sequencing primer (read 2 sequencing primer) that binds to the complementary sequence of the primer (eg, i7 sequencing primer) binds to a second sequencing binding site (eg, SBS12'), resulting in the synthesis and sequencing of the insert sequence in the reverse direction.
[0121] Solid carrier
[0122] The present disclosure can utilize a solid carrier composed of a substrate or matrix (e.g., a glass slide, polymer beads, etc.) that has been functionalized, for example, by applying an intermediate material layer or coating containing reactive groups that allow attachment to biomolecules such as polynucleotides. Examples of such carriers include, but are not limited to, substrates such as glass. In such embodiments, biomolecules (e.g., polynucleotides) can be directly covalently attached to the intermediate material, but the intermediate material itself can be non-covalently attached to the substrate or matrix (e.g., a glass substrate). The term "covalently attached to a solid carrier" should be interpreted accordingly to encompass this type of arrangement. Alternatively, a substrate (such as glass) can be treated to allow direct covalent attachment of biomolecules. In some embodiments, a pad coated with streptavidin is placed on a solid support. Streptavidin can bind to a template connected to biotin.
[0123] Amplification and sequencing of template strand
[0124] Once a library comprising template nucleotide chains is prepared, the templates are seeded onto a solid support and then amplified to produce clusters of single template molecules.
[0125] As a simple example, after attaching P5 and P7 primers, the solid support can be contacted with the template to be amplified under conditions that allow hybridization (or annealing-such terms can be used interchangeably) between the template and the fixed primer (also referred to as "moss primer" in this article). The template is usually added in a free solution under suitable hybridization conditions, which will be obvious to the technician. Usually, the hybridization conditions are, for example, 5xSSC at 40°C. Solid phase amplification can then be performed. The first step of amplification is a primer extension step, in which nucleotides are added to the 3' end of the fixed primer using a template to produce a fully extended complementary chain. The template is then usually washed off from the solid support. The complementary chain will include a primer binding sequence (i.e., the complementary sequence of P5 or P7) at its 3' end, which can be bridged and combined with a second primer molecule fixed on a solid support in some methods. In this method, another round of amplification (similar to a standard PCR reaction) results in the formation of a cluster or colony of template molecules bound to a solid support. Therefore, in this method, solid phase amplification by a method similar to WO 98 / 44151 or WO 00 / 18957 (the contents of which are incorporated herein by reference in their entirety) will result in a cluster array of colonies containing "bridging" amplification products. The two chains of the amplification product will be fixed to the solid support at or near the 5' end, and this attachment is derived from the initial attachment of the amplification primer. Typically, the amplification product in each colony will be derived from the amplification of a single template (target) molecule. Other amplification procedures can be used and will be known to the technician. For example, amplification can be isothermally amplified using a strand displacement polymerase; or it can be an exclusion amplification as described in WO 2013 / 188582, the entire contents of which are incorporated herein by reference. The method may also involve multiple rounds of invasion by competitive fixed primers (or moss primers) and strand displacement of the template to the competitive primer. Further information about amplification can be found in WO0206456 and WO07107710, and the entire contents of each of these documents are incorporated herein by reference. By such methods, clusters of single template molecules are formed.
[0126] By obtaining the sequence read by one strand of the template from the primer in the solution, using the fixed primer to copy the strand, releasing the first strand and sequencing the second replicated strand, sequence data can be obtained from the two ends of the template duplex. For example, sequence data can be obtained from the two ends of the fixed duplex by such a method: wherein the duplex is treated to release the 3'-hydroxyl moiety that can be used as an extension primer. Then the first sequence can be read from one strand of the template using an extension primer. After the first reading, the strand can be extended to fully replicate all bases until the end of the first strand. The second copy remains attached to the surface of the 5' end. When the first strand is removed from the surface, the sequence of the second strand can be read. This gives a sequence read from the two ends of the original fragment. The process of regeneration of the strand after the first reading is called "paired end resynthesis" or "PE resynthesis". The typical steps of paired sequencing are known and described in WO 2008 / 041002, the entire content of which is incorporated herein by reference.
[0127] Any suitable "synthesis sequencing" technique can be used for sequencing, in which nucleotides are continuously added to free 3' hydroxyl groups, resulting in the synthesis of polynucleotide chains in the 5' to 3' direction. The properties of the added nucleotides are preferably determined after each addition. A specific sequencing method relies on the use of modified nucleotides that can act as reversible chain terminators. Such reversible chain terminators include removable 3' blocking groups. Once such modified nucleotides have been incorporated into the growing polynucleotide chain complementary to the template region to be sequenced, there is no free 3'-OH group available to guide further sequence extension, so the polymerase cannot add additional nucleotides. Once the properties of the bases incorporated into the growing chain have been determined, the 3' block can be removed to allow the addition of the next continuous nucleotide. By sorting the products derived from these modified nucleotides, the DNA sequence of the DNA template can be inferred. If each of the modified nucleotides has been attached with different tags known to correspond to specific bases, it is beneficial to distinguish the bases added at each incorporation step, then such reactions can be completed in a single experiment. Suitable labels are described in PCT application WO 2007 / 135368, the entire contents of which are incorporated herein by reference. Alternatively, separate reactions containing each modified nucleotide added separately may be performed.
[0128] Modified nucleotides can carry labels to facilitate their detection. In a specific embodiment, the label is a fluorescent label. Each nucleotide type can carry different fluorescent labels. However, detectable labels do not need to be fluorescent labels. Any label that allows detection of nucleotide incorporation into a DNA sequence can be used. A method for detecting fluorescently labeled nucleotides includes using a laser with a specific wavelength for the labeled nucleotide, or using other suitable illumination sources. The fluorescence from the label on the incorporated nucleotide can be detected by a CCD camera or other suitable detection methods. Suitable detection methods are described in WO 2007 / 123744, the entire contents of which are incorporated herein by reference.
[0129] Alternative sequencing methods include sequencing by ligation, for example, as described in US Pat. No. 6,306,597 or WO06084132, each of which is incorporated herein by reference in its entirety.
[0130] The extension reaction is performed using a polymerase such as a DNA or RNA polymerase, wherein nucleotides are added to the 3' end of the primer. In one embodiment, the polymerase is a non-thermal isothermal strand displacement polymerase. Suitable non-thermostable strand displacement polymerases according to the present disclosure can be found, for example, by New England BioLabs, Inc., and include phi29, Bsu, Klenow, DNA polymerase I (E. coli), and thermistor. A particularly preferred polymerase is Bsu.
[0131] References to P5 and P7 may refer to different primer sequences. The present disclosure contemplates any suitable primer sequence combination.
[0132] Example
[0133] The following representative examples are representative of the embodiments described herein and are not meant to be limiting in any way.
[0134] Example 1. Method for performing monoclonal clustering on a flow cell
[0135] The flow cell surface was prepared with orthogonal chemistries for clustering and seeding. Figure 1 As shown, seeding can only be performed on pads coated with streptavidin 10, while clustering can occur in areas coated with PAZAM grafted with standard P5 / P7 chemistry 15.
[0136] like Figure 2 As shown, during library preparation, the template DNA 20 is labeled with a ligand such as biotin 25 to enable seeding on a streptavidin pad. The library remains as double-stranded DNA (dsDNA), which has a much larger radius of gyration than single-stranded DNA. Because the DNA is dsDNA, non-specific and self-interactions are blocked 30.
[0137] As a result, seeding results in size exclusion, which reduces the probability of multiple seeding events occurring on a single cluster. That is, once a streptavidin pad has been seeded with a single dsDNA template molecule, the large footprint of that molecule tends to limit other seeding events on the same pad.
[0138] dsDNA seeding reduces (1) nonspecific interactions between ssDNA molecules that lead to bunching of library molecules, which can result in non-Poisson seeding that is biased toward polyclonal clusters and (2) nonspecific self-interactions that lead to secondary DNA structures that can hinder seeding or clustering.
[0139] The small conjugate pads can be formed in a variety of ways. Figure 3A As shown, a small conjugate pad 35 can be formed on the flow cell surface 40 without a pore structure. Figure 3B As shown, a small conjugate pad 45 can be formed on a small hole structure 50 on a flow cell surface 55. Figure 3C As shown, small conjugate pads 60 may be formed within small holes 65 within large holes 70 on the flow cell surface 75 .
[0140] To increase the speed at which seeding occurs, this method can optionally be combined with the use of cleavable, positively charged molecules added to the ends of the surface primers. Figure 4 An embodiment of a flow cell surface 80 comprising surface primers 85 is provided. Each surface primer contains a cleavable positive charge 90 that promotes the migration of dsDNA to the surface of the flow cell. Specifically, the positive charge will act as a binding funnel to attract negatively charged dsDNA template strands to the surface, thereby increasing their likelihood of interacting with the streptavidin pad via diffusion.
[0141] Example 2. Effect of dsDNA radius of gyration on monoclonal fractions
[0142] It is known that dsDNA has a larger radius of gyration than ssDNA. A 1,000 base pair strand of dsDNA yields a radius of about 70 nm (Douglas R. Tree, Abhiram Muralidhar, Patrick S. Doyle, and Kevin D. Dorfman, Is DNA a Good Model Polymer? Macromolecules 46, 20, 8369-8382 (2013)). Due to this radius of gyration, dsDNA has a larger exclusion coverage area when seeded relative to ssDNA.
[0143] In the simulation, random seeding locations were drawn on a grid of nanopores. Template strands were assumed to be non-overlapping. Some overlap of the template and the pore was required for binding to occur. Figure 5A and5B The simulation data generated in the bar graph shown in was generated using a 70 nm radius of gyration and a 100 nm pad. Assuming a 100 nm pad is available for manufacturing, smaller pads are also possible.
[0144] Figure 5A A simulation of seeding is shown, assuming a 15% overlap between the template and the wells. Element 95 shows a histogram of the seeding distribution without size exclusion. Figure 5B A simulation of seeding is shown, assuming that a 30% overlap between the template and the wells is required. Element 100 shows a histogram of the seeding distribution without size exclusion.
[0145] Simulations were performed until 90% of the wells were occupied. If 50 nm pads could be made, simulations indicated that seeding with 70 nm dsDNA could make 80-90+% of the occupied wells monoclonal.
[0146] Figure 6 Sampling from Monte Carlo simulation is illustrated, which shows the fraction of holes inoculated with various possible parameters (such as pore radius, DNA radius of gyration and DNA overlap) monoclonal. Thousands of holes and dsDNA chains have been tested. In the simulation, it is assumed that the DNA molecules of each simulation interact at random positions on the flow cell. If the coverage area of DNA (defined by its assumed radius of gyration) lacks enough overlap with cells, it is assumed that the DNA chain is not inoculated in the simulation. In addition, if the DNA chain only overlaps with the hole occupied by another DNA chain, it is assumed that the DNA chain is not inoculated in the simulation. However, if the DNA chain overlaps with the hole at a position not previously inoculated, it is assumed that the DNA chain is seeded in the hole it overlaps. This inoculation event prevents other DNA chains from being seeded in the hole.
[0147] Table 1 shows the seeding percentages for this model system if there is no size exclusion, if a 15% overlap between the template and the wells is required, and if a 30% overlap between the template and the wells is required.
[0148] Table 1 .
[0149] 1 vaccination 2 vaccinations 3 vaccinations 4 vaccinations No size exclusion 23.2% 26.6% 20.4% 19.9% 15% overlap required 48.8% 35.8% 5.4% 0.1% 30% overlap required 59.7% 28.5% 1.8% 0%
[0150] Example 3. Binding Energy Funnel
[0151] Fig. 8A Embodiments of binding energy funnels are provided in which a cleavable positively charged group is attached to a lawn primer. For example, cleavage can occur by cleaving a disulfide bond. Figure 8B An embodiment of a binding energy funnel is provided in which a complementary lawn primer is attached to a positively charged group. The positively charged group can be removed by melting.
[0152] Example 4. Mechanism of action of the binding energy funnel
[0153] Fig.9A and 9B Examples of mechanisms of action of binding energy funnels are provided. Fig.9A As shown, due to the positive charge 205 at the end of the lawn primer 210, the template strand 200 diffuses (as shown by the arrow) to the surface of the flow cell. The positive charge on the lawn primer can be molecules of various lengths or molecules of various sizes so that they can fully neutralize the repulsive force of the negative charge of the surface primer. Various sizes and lengths of molecules are described herein. Molecules containing multiple positive charges such as polylysine can also be used. Other molecules containing multiple positive charges are described herein. In addition, the ionic strength can also be adjusted to reduce electrostatic repulsion. Alternatively, the pH of the buffer solution can also be controlled to control the effective positive charge on the surface. As shown in FIG. Fig. 9B As shown, as the template strands diffuse near the surface, they are captured on the streptavidin pad 215 through the interaction of the biotin tag 220 with the streptavidin.
[0154] The binding energy between the biotin and streptavidin pad is much higher than the weak primer charge interaction. In addition, the positive charge on the lawn primer creates a lower energy state near the surface of the flow cell relative to the rest of the fluidic channel on the flow cell ( Fig. 9C ).
[0155] Example 5. Exemplary method for monoclonal clustering using dsDNA
[0156] Fig.10 An exemplary method for monoclonal clustering using dsDNA is provided. The method comprises the following steps:
[0157] 1. Create a streptavidin pad on the flow cell surface.
[0158] 2. Add surface primers covered with mild positive charges to the flow cell surface.
[0159] 3. Double-stranded DNA (dsDNA) bound to biotin is seeded onto the surface of the flow cell. The dsDNA contains the target nucleic acid sequence and the complementary nucleic acid sequence. Large dsDNA improves monoclonality relative to smaller pads.
[0160] 4. The mild positive charge is removed from the surface primer.
[0161] 5. Melt the DNA to remove complementary nucleic acid sequences.
[0162] 6. Sequence the target nucleic acid to determine its identity. The target can be amplified by examplification or bridge amplification. Example 5 describes dsDNA combined with lawn primers that can be amplified by ex-amp or bridge amplification.
[0163] It should be understood that any corresponding features / examples of each of the aspects of the present disclosure as described herein may be implemented together in any appropriate combination, and any features / examples from any one or more of these aspects may be implemented together with any of the features of the other (multiple) aspects as described herein in any appropriate combination to achieve the benefits as described herein.
Claims
1. A method for amplifying a target nucleic acid sequence, the method comprising: include: Inoculating a double-stranded DNA (dsDNA) onto a flow cell, the flow cell comprising a first part and a second part, the first part comprising a protein, the second part comprising a plurality of lawn primers immobilized on the flow cell, wherein the dsDNA comprises a target nucleic acid sequence and a complementary nucleic acid sequence, and wherein the dsDNA is linked to a ligand, resulting in an interaction between the ligand and the protein; After the ligand interacts with the protein, denaturing the dsDNA to remove complementary nucleic acid sequences; and The target nucleic acid sequence is amplified using the lawn primers.
2. The method according to claim 1, wherein one end of the plurality of lawn primers is capped with a positive charge.
3. The method of claim 2, wherein the positive charge causes the dsDNA to diffuse toward the first portion of the flow cell containing the protein.
4. The method of claim 2, further comprising removing the positive charge from the lawn primer after the ligand interacts with the protein.
5. The method of claim 4, wherein the positive charge is removed by lysis.
6. The method of claim 4, wherein the positive charges are removed by melting.
7. The method of claim 1, wherein the protein is streptavidin, and wherein the ligand is biotin.
8. The method of claim 1, wherein the lawn primer comprises a P5 lawn primer.
9. The method of claim 1, wherein the lawn primer comprises a P7 lawn primer.
10. The method of claim 1, wherein the lawn primers include P5 and P7 lawn primers.
11. The method of claim 1, wherein the flow cell does not include any holes on its surface.
12. The method of claim 1, wherein the flow cell comprises holes on its surface.
13. The method of claim 12, wherein the pores comprise small pores within larger pores.
14. The method of claim 1, wherein seeding the dsDNA onto the flow cell inhibits other seeding events on the flow cell.
15. The method of claim 1, wherein the first portion of the flow cell is circular.
16. The method of claim 15, wherein the first portion of the flow cell comprises a diameter between 80 nm and 100 nm.
17. The method of claim 15, wherein the first portion of the flow cell is a circular pad.
18. A method for seeding a double-stranded DNA (dsDNA) onto a flow cell, the method comprising: include: The dsDNA is inoculated onto the flow cell, wherein the flow cell comprises a first part and a second part, wherein the first part comprises a first biomolecule, and the second part comprises a plurality of lawn primers fixed on the flow cell, wherein the dsDNA comprises a target nucleic acid sequence, and wherein the dsDNA is linked to a second biomolecule, resulting in an interaction between the second biomolecule and the first biomolecule.
19. The method of claim 18, wherein the first biomolecule and the second biomolecule interact via covalent interactions.
20. The method of claim 18, wherein the first biomolecule and the second biomolecule interact via non-covalent interactions.
21. The method of claim 20, wherein the non-covalent interaction comprises a protein-ligand interaction.
22. The method of claim 21, wherein the protein-ligand interaction comprises a streptavidin-biotin interaction.
23. A circulation cell, the circulation cell include: A surface, the surface comprising: A first part comprising a protein-containing pad; and The second part comprises at least one of a P5 lawn primer and a P7 lawn primer.
24. The flow cell of claim 23, wherein the second portion comprises both P5 and P7 lawn primers.
25. The flow cell of claim 23, wherein at least one of the P5 lawn primer and the P7 lawn primer is capped with a positive charge.
26. A flow cell according to claim 23, wherein the surface comprises a patterned surface.
27. A flow cell according to claim 26, wherein the patterned surface comprises at least one hole.
28. A flow cell according to claim 27, wherein the at least one hole comprises at least one small hole contained within at least one large hole.
29. The flow cell of claim 26, wherein the patterned surface comprises a gel.
30. The flow cell of claim 29, wherein the gel comprises poly(N-(5-azidoacetamidopentyl)acrylamide-co-acrylamide) (PAZAM).
31. A circulation cell, the circulation cell include: a surface coated with primers capped with a positive charge; and A pad comprising a protein, wherein the pad has a higher binding energy to dsDNA than a primer capped with a positive charge.
32. A flow cell according to claim 31, wherein the positive charge produces a lower energy state at the surface of the flow cell.
33. The flow cell of claim 31 , wherein the protein comprises streptavidin.
34. The flow cell of claim 31 , wherein the positive charge is cleavable such that it can be removed from the primer.
Citation Information
Patent Citations
Method of nucleic acid amplification
WO1998044151A1
Methods of nucleic acid amplification and sequencing
WO2000018957A1
Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
WO2002006456A1
Nucleic acid characterisation
WO2005068656A1
Reagents, methods, and libraries for bead-based squencing
WO2006084132A2
